What if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast world of passive crypto income, where you set up a dependable income stream that works for you, whether you're at your computer or living your life.

>> Secure Your Spot On The Groundbreaking Workshop Here

SLRN Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 13.60%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $198,554.77

Acelyrin Insider Trading History Chart

Acelyrin Share Price & Price History

^$5.10

▲ +0.36 (7.59%)

As of 10/10/2024 01:49 PM ET

Days: 30 | 90 | 365

Ezekiel 7:23

From Paradigm Press | Ad

Jim Rickards here - former advisor to the CIA, the White House, and the Pentagon - with an urgent warning regarding the 2024 election. I don’t want to frighten you. But as an American patriot, it is my Christian duty to share the illegal election plot I’ve just uncovered. See, the Kamala campaign may be planning something so egregious… so despicable… and frankly, so unconstitutional that it could completely destroy our country. I predict a 50% market crash… Violent riots in the streets… And the potential introduction of martial law.

It’s a scenario that only the Holy Bible could predict.

Acelyrin Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
7/17/2024	Daniel J Becker	Director	Sell	1	$6.86	$6.86	2,999
2/20/2024	Shao-Lee Lin	CEO	Sell	15,701	$7.60	$119,327.60	1,587,335
1/2/2024	Shao-Lee Lin	CEO	Sell	10,691	$7.41	$79,220.31	1,603,036
5/9/2023	Beth C Seidenberg	Director	Buy	60,000	$18.00	$1,080,000.00	60,000
5/9/2023	Biopartners Fund Ii Westlake	Major Shareholder	Buy	1,250,000	$18.00	$22,500,000.00	9,790,729
5/9/2023	Mardi Dier	CFO	Buy	5,556	$18.00	$100,008.00	5,556
5/9/2023	Ronald Oyston	Insider	Buy	1,000	$18.00	$18,000.00	1,000

No matter the outcome of the election, it could be a death sentence for your wealth...

From Allegiance Gold | Ad

In today's financial landscape, many investors are feeling disillusioned and disappointed with traditional investment options.

So, Why Gold? Why Now?

SEC Filings (Institutional Ownership Changes) for Acelyrin (NASDAQ:SLRN)

87.31% of Acelyrin stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Acelyrin Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
10/3/2024	SG Americas Securities LLC	26,755	$0.13M	0.0%	+129.6%	0.027%
9/16/2024	Cubist Systematic Strategies LLC	90,022	$0.40M	0.0%	+158.1%	0.090%
9/4/2024	Ghisallo Capital Management LLC	17,500	$77K	0.0%	-50.0%	0.018%
8/19/2024	Point72 Asset Management L.P.	37,542	$0.17M	0.0%	-83.2%	0.038%
8/16/2024	Almitas Capital LLC	376,116	$1.66M	0.7%	N/A	0.380%
8/15/2024	Susquehanna Fundamental Investments LLC	160,167	$0.71M	0.0%	N/A	0.162%
8/15/2024	Blue Owl Capital Holdings LP	2,926,028	$12.90M	3.6%	+3.5%	2.955%
8/15/2024	The Manufacturers Life Insurance Company	29,769	$0.13M	0.0%	+16.3%	0.030%
8/15/2024	Millennium Management LLC	4,642,056	$20.47M	0.0%	+15.7%	4.688%
8/14/2024	Squarepoint Ops LLC	78,023	$0.34M	0.0%	N/A	0.079%
8/14/2024	Cubist Systematic Strategies LLC	90,022	$0.40M	0.0%	+158.1%	0.091%
8/14/2024	ProShare Advisors LLC	15,841	$70K	0.0%	-20.3%	0.016%
8/12/2024	XTX Topco Ltd	43,300	$0.19M	0.0%	N/A	0.044%
8/9/2024	Renaissance Technologies LLC	397,618	$1.75M	0.0%	+218.0%	0.402%
8/6/2024	Acadian Asset Management LLC	134,184	$0.59M	0.0%	N/A	0.135%
8/6/2024	Los Angeles Capital Management LLC	157,093	$0.69M	0.0%	N/A	0.159%
8/1/2024	Rhumbline Advisers	108,384	$0.48M	0.0%	+25.3%	0.109%
7/29/2024	Principal Financial Group Inc.	11,038	$49K	0.0%	N/A	0.011%
7/26/2024	Bank of New York Mellon Corp	223,395	$0.99M	0.0%	+22.5%	0.226%
7/20/2024	Nisa Investment Advisors LLC	14,081	$62K	0.0%	+58,570.8%	0.014%
7/12/2024	SG Americas Securities LLC	11,654	$51K	0.0%	N/A	0.012%
5/29/2024	Opaleye Management Inc.	1,580,000	$10.67M	2.3%	-61.9%	1.596%
5/20/2024	Virtu Financial LLC	21,834	$0.15M	0.0%	N/A	0.022%
5/17/2024	Artal Group S.A.	2,405,143	$16.24M	0.4%	-20.8%	2.429%
5/17/2024	Ikarian Capital LLC	1,564,340	$10.56M	1.2%	-32.8%	1.580%
5/16/2024	California State Teachers Retirement System	7,301	$49K	0.0%	-67.9%	0.007%
5/16/2024	Jacobs Levy Equity Management Inc.	586,746	$3.96M	0.0%	N/A	0.593%
5/16/2024	Kennedy Capital Management LLC	486,560	$3.28M	0.1%	+2.6%	0.492%
5/16/2024	Kynam Capital Management LP	396,379	$2.68M	0.3%	-67.0%	0.401%
5/15/2024	Public Employees Retirement System of Ohio	28,418	$0.19M	0.0%	N/A	0.029%
5/15/2024	Price T Rowe Associates Inc. MD	20,703	$0.14M	0.0%	N/A	0.021%
5/14/2024	EntryPoint Capital LLC	11,033	$74K	0.1%	-47.4%	0.011%
5/14/2024	StemPoint Capital LP	714,773	$4.83M	1.3%	+21.7%	0.723%
5/14/2024	American International Group Inc.	35,793	$0.24M	0.0%	+117.3%	0.036%
5/13/2024	Ameritas Investment Partners Inc.	7,243	$49K	0.0%	+118.0%	0.007%
5/10/2024	Vanguard Group Inc.	6,237,543	$42.10M	0.0%	+1.3%	6.306%
5/9/2024	Blair William & Co. IL	138,595	$0.94M	0.0%	N/A	0.140%
5/8/2024	ProShare Advisors LLC	19,871	$0.13M	0.0%	+69.9%	0.020%
5/8/2024	Russell Investments Group Ltd.	27,108	$0.18M	0.0%	N/A	0.027%
4/29/2024	China Universal Asset Management Co. Ltd.	18,718	$0.13M	0.0%	+66.2%	0.019%
2/14/2024	Point72 Europe London LLP	122,971	$0.92M	0.1%	N/A	0.126%
2/14/2024	Superstring Capital Management LP	356,924	$2.66M	1.9%	N/A	0.367%
2/14/2024	Lighthouse Investment Partners LLC	86,651	$0.65M	0.0%	N/A	0.089%
2/14/2024	Sectoral Asset Management Inc.	325,549	$2.43M	1.0%	N/A	0.334%
2/12/2024	Capstone Investment Advisors LLC	27,345	$0.20M	0.0%	N/A	0.028%
2/12/2024	Decheng Capital LLC	1,370,951	$10.23M	2.9%	N/A	1.408%
2/9/2024	Dynamic Technology Lab Private Ltd	14,431	$0.11M	0.0%	N/A	0.015%
2/7/2024	Jump Financial LLC	49,500	$0.37M	0.0%	+152.7%	0.051%
2/6/2024	Swiss National Bank	38,300	$0.29M	0.0%	-40.2%	0.039%
2/1/2024	New York State Common Retirement Fund	13,181	$98K	0.0%	+84.4%	0.014%
1/30/2024	Zurcher Kantonalbank Zurich Cantonalbank	10,716	$80K	0.0%	+608.3%	0.011%
1/30/2024	Strs Ohio	42,300	$0.32M	0.0%	+504.3%	0.043%
1/30/2024	Vontobel Holding Ltd.	325,549	$2.43M	0.0%	N/A	0.334%
1/24/2024	Mirae Asset Global Investments Co. Ltd.	17,038	$0.13M	0.0%	-15.6%	0.018%
1/24/2024	China Universal Asset Management Co. Ltd.	11,259	$84K	0.0%	N/A	0.012%
1/16/2024	Raymond James & Associates	10,522	$78K	0.0%	-43.3%	0.011%
1/12/2024	SG Americas Securities LLC	14,741	$0.11M	0.0%	N/A	0.015%
12/18/2023	Vanguard Group Inc.	3,189,027	$32.43M	0.0%	+3.8%	3.276%
12/6/2023	Citigroup Inc.	73,269	$0.75M	0.0%	N/A	0.075%
11/29/2023	Decheng Capital Management III Cayman LLC	1,548,317	$15.75M	4.0%	-0.4%	1.591%
11/21/2023	Walleye Capital LLC	447,355	$4.55M	0.0%	N/A	0.460%
11/15/2023	Kynam Capital Management LP	1,200,000	$12.20M	2.0%	N/A	1.233%
11/15/2023	Adage Capital Partners GP L.L.C.	100,000	$1.02M	0.0%	-73.0%	0.103%
11/14/2023	venBio Partners LLC	3,852,470	$39.18M	11.1%	-0.1%	3.962%
11/14/2023	Schonfeld Strategic Advisors LLC	202,662	$2.06M	0.0%	+267.1%	0.208%
11/14/2023	Fred Alger Management LLC	53,206	$0.54M	0.0%	-94.7%	0.055%
11/14/2023	Profund Advisors LLC	29,232	$0.30M	0.0%	N/A	0.030%
11/13/2023	Eagle Asset Management Inc.	358,363	$3.65M	0.0%	-31.1%	0.369%
11/13/2023	CHI Advisors LLC	2,262,990	$23.02M	6.9%	-15.0%	2.327%
11/13/2023	FMR LLC	8,961,726	$89.91M	0.0%	+20.2%	9.216%
11/13/2023	Rafferty Asset Management LLC	173,696	$1.77M	0.0%	N/A	0.179%
11/9/2023	Citigroup Inc.	73,269	$0.75M	0.0%	N/A	0.075%
11/8/2023	Ausdal Financial Partners Inc.	21,000	$0.21M	0.0%	N/A	0.022%
11/8/2023	Swiss National Bank	64,100	$0.65M	0.0%	N/A	0.066%
11/8/2023	Amalgamated Bank	4,281	$44K	0.0%	N/A	0.004%
11/7/2023	New York State Common Retirement Fund	7,149	$73K	0.0%	N/A	0.007%
11/7/2023	Barclays PLC	106,688	$1.08M	0.0%	N/A	0.110%
11/7/2023	Jump Financial LLC	19,592	$0.20M	0.0%	-17.3%	0.020%
10/27/2023	TD Asset Management Inc	75,164	$0.76M	0.0%	+22.0%	0.077%
10/26/2023	Mirae Asset Global Investments Co. Ltd.	20,196	$0.21M	0.0%	N/A	0.021%
10/26/2023	Strs Ohio	7,000	$71K	0.0%	N/A	0.007%
10/24/2023	Bank of New York Mellon Corp	92,701	$0.94M	0.0%	+601.1%	0.095%
10/24/2023	Raymond James & Associates	18,556	$0.19M	0.0%	N/A	0.019%
8/24/2023	Perceptive Advisors LLC	200,000	$4.18M	0.1%	N/A	0.206%
8/22/2023	CHI Advisors LLC	2,663,806	$55.67M	16.8%	N/A	2.739%
8/15/2023	Braidwell LP	500,000	$10.45M	0.3%	N/A	0.514%
8/14/2023	Samsara BioCapital LLC	2,256,022	$47.15M	8.3%	N/A	2.321%
8/14/2023	Marshall Wace LLP	1,161,528	$24.28M	0.0%	N/A	1.195%
8/14/2023	Rock Springs Capital Management LP	141,876	$2.97M	0.1%	N/A	0.146%
8/14/2023	Driehaus Capital Management LLC	1,758,797	$36.76M	0.5%	N/A	1.809%
8/14/2023	Ghisallo Capital Management LLC	70,000	$1.46M	0.2%	N/A	0.072%
8/11/2023	AyurMaya Capital Management Company LP	9,334,735	$195.10M	100.0%	N/A	9.604%
8/11/2023	General Atlantic L.P.	1,500,000	$31.35M	0.5%	N/A	1.543%
8/11/2023	Sectoral Asset Management Inc.	201,017	$4.20M	0.7%	N/A	0.207%
8/11/2023	Landscape Capital Management L.L.C.	15,426	$0.32M	0.0%	N/A	0.016%
8/11/2023	Franklin Resources Inc.	879,268	$18.38M	0.0%	N/A	0.905%
8/11/2023	Artal Group S.A.	1,821,214	$38.06M	1.2%	N/A	1.874%
8/11/2023	JPMorgan Chase & Co.	3,703,338	$77.40M	0.0%	N/A	3.810%
8/11/2023	ExodusPoint Capital Management LP	111,077	$2.32M	0.0%	N/A	0.114%
8/9/2023	TD Asset Management Inc	61,610	$1.29M	0.0%	N/A	0.063%

Data available starting January 2016

Acelyrin, Inc., a clinical biopharma company, focuses on identifying, acquiring, and accelerating the development and commercialization of transformative medicines. The company's lead product candidate is izokibep, a small protein therapeutic designed to inhibit IL-17A with high potency, which is in Phase 3 clinical trials for use in the treatment of Hidradenitis Suppurativa, Psoriatic Arthritis, and uveitis, as well as in Phase 2 clinical trials for use in the treatment of Axial Spondyloarthritis. It is also developing lonigutamab, a humanized immunoglobulin G1 (IgG1) monoclonal antibody which is in Phase 1 clinical trials for use in the treatment of thyroid eye disease. In addition, the company's develops SLRN-517, a fully human IgG1 monoclonal antibody targeting c-KIT, which is in preclinical stage for use in the treatment of chronic urticaria. Acelyrin, Inc. was incorporated in 2020 and is headquartered in Agoura Hills, California.

Today's Range

Now: $5.10

$4.66

$5.10

50 Day Range

MA: $4.80

$3.98

$5.74

52 Week Range

Now: $5.10

$3.36

$10.70

Volume

142,339 shs

Average Volume

1,079,473 shs

Market Capitalization

$509.03 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.33

Who are the company insiders with the largest holdings of Acelyrin?: Acelyrin's top insider investors include:
Biopartners Fund Ii Westlake (Major Shareholder)
Shao-Lee Lin (CEO)
Beth C Seidenberg (Director)
Mardi Dier (CFO)
Daniel J Becker (Director)
Ronald Oyston (Insider)
Learn More about top insider investors at Acelyrin.
Who are the major institutional investors of Acelyrin?: Acelyrin's top institutional shareholders include:
SG Americas Securities LLC — 0.03%
Learn More about top institutional investors of Acelyrin stock.
Which major investors are buying Acelyrin stock?: Within the previous quarter, SLRN stock was acquired by institutional investors including:
SG Americas Securities LLC
Within the last year, these company insiders have bought Acelyrin stock:
Biopartners Fund Ii Westlake (Major Shareholder)
Shao-Lee Lin (CEO)
Beth C Seidenberg (Director)
Mardi Dier (CFO)
Learn More investors buying Acelyrin stock.

24/7 Automated Profits in Crypto

From Crypto Swap Profits | Ad